Switching medications for nonmedical (formulary) reasons in long-term care settings may increase Medicare Part D resident adverse effects and raise facility downstream costs.
Bryan R. Cote, MA
Advertisement
Articles by Bryan R. Cote, MA
Advertisement
Latest Updated Articles
- Impact of Therapeutic Switching in Long-Term Care
November 15th 2008
Advertisement
Advertisement
Trending on AJMC
1
Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies
2
Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers
3
Upcoming 2026 FDA Decisions Could Expand Treatment Options Across Oncology and Hepatitis B
4
The Future of Myeloma Treatment: Ajai Chari, MD
5